ORIC Pharmaceuticals (FRA:4TZ) Days Payable: 0.00 (As of Mar. 2026)

What is ORIC Pharmaceuticals Days Payable?

ORIC Pharmaceuticals FRA:4TZ -2.77% 32 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates FRA:4TZ with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 701 Biotechnology companies, ORIC Pharmaceuticals ranks worse than 142653.21% on this metric.

ORIC Pharmaceuticals's average Accounts Payable for the three months ended in Mar. 2026 was €2.89 Mil. ORIC Pharmaceuticals's Cost of Goods Sold for the three months ended in Mar. 2026 was €0.00 Mil.

The historical rank and industry rank for ORIC Pharmaceuticals's Days Payable or its related term are showing as below:

FRA:4TZ's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

ORIC Pharmaceuticals's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

ORIC Pharmaceuticals Days Payable Related Terms

ORIC Pharmaceuticals Days Payable Historical Data

* Premium members only.

The historical data trend for ORIC Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ORIC Pharmaceuticals Days Payable Chart

ORIC Pharmaceuticals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Days Payable

Get a 7-Day Free Trial

0.00

ORIC Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:4TZ vs DRTS, OLMA, KURA: Days Payable Comparison

For the Biotechnology subindustry, ORIC Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ORIC Pharmaceuticals Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ORIC Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where ORIC Pharmaceuticals's Days Payable falls into.

Save Embed

32GF Score

ORIC Pharmaceuticals Inc FRA:4TZ

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ORIC Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

ORIC Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

	Days Payable (A: Dec. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2024 )	+	Accounts Payable (A: Dec. 2025 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2025 )	*	Days in Period
=	( (1.478	+	3.266)	/	2 )	/	0	*	365
=	2.372					/	0	*	365
=	N/A

ORIC Pharmaceuticals's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (3.266	+	2.504)	/	2 )	/	0	*	365 / 4
=	2.885					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

ORIC Pharmaceuticals (FRA:4TZ) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ORIC Pharmaceuticals and its competitors. According to the industry distribution chart, ORIC Pharmaceuticals ranks #999999 out of 701 companies in the Biotechnology industry.

Is ORIC Pharmaceuticals' Days Payable too high?

ORIC Pharmaceuticals' current Days Payable is 0.00. Based on the distribution chart, ORIC Pharmaceuticals ranks #999999 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, ORIC Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.

How does ORIC Pharmaceuticals' Days Payable compare to DRTS and OLMA?

According to the Biotechnology industry distribution chart, ORIC Pharmaceuticals ranks #999999 out of 701 companies for Days Payable. This places ORIC Pharmaceuticals in the lower half of its industry. The industry median Days Payable is 112.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on ORIC Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ORIC Pharmaceuticals's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ORIC Pharmaceuticals stock overvalued right now?

ORIC Pharmaceuticals (FRA:4TZ) has a current Days Payable of 0.00. The current Days Payable is 0.00. ORIC Pharmaceuticals' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For ORIC Pharmaceuticals (FRA:4TZ), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ORIC Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies DRTS OLMA KURA REPL AVTX SANA ANRO LBRX MRVI SLDB VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges ORIC:USA

Address 240 E. Grand Avenue, 2nd Floor, South San Francisco, CA, USA, 94080

Website https://www.oricpharma.com

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

32GF Score

Get the complete analysis for FRA:4TZ

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.13

Price

View FRA:4TZ Analysis

See Days Payable data for all stocks →